Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Favezelimab (Anti-LAG3 / CD223) For research use only.
Not for use in humans.

Favezelimab (Anti-LAG3 / CD223)

Synonyms: MK-4280

Favezelimab (Anti-LAG3 / CD223) is a humanized monoclonal antibody that targets LAG-3. It has the potential for colorectal cancer (CRC) research. MW :145.98 KD.

Favezelimab (Anti-LAG3 / CD223)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Favezelimab (Anti-LAG3 / CD223) is a humanized monoclonal antibody that targets LAG-3. It has the potential for colorectal cancer (CRC) research. MW :145.98 KD.

Product Details

CAS No. 2231068-83-8
Molecular Weight 145.98
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Favezelimab (Anti-LAG3 / CD223) | Favezelimab (Anti-LAG3 / CD223) supplier | purchase Favezelimab (Anti-LAG3 / CD223) | Favezelimab (Anti-LAG3 / CD223) cost | Favezelimab (Anti-LAG3 / CD223) manufacturer | order Favezelimab (Anti-LAG3 / CD223) | Favezelimab (Anti-LAG3 / CD223) distributor